黑殭菌素B在動物模式中對人類大腸癌腫瘤的抑制效果之研究探討

In Vivo Inhibitory Effects of Destruxin B on Human Colorectal Cancer

廖婉君(Wan-chun Liao)

指導教授 ： 楊繼江 ； 曾耀銘

朝陽科技大學/理工學院/生化科技研究所/碩士(2010年)

摘要

大腸癌是惡性腫瘤中三大死亡原因之一。根據先前研究顯示，Metarhizium Anisopliae 的二次代謝產物黑殭菌素B (Destruxin B)具有抑制人類大腸癌細胞株 HT-29 生長的功效。本實驗目的為比較destruxin B 在動物體內、體外抗大腸癌細胞活性的能力，以及研究其在動物體內抑制大腸癌的可能機制。根據Chen 等人(1999) 的研究分離純化出黑殭菌素，並且利用分析型HPLC、ESI-MASS 以及 1H NMR 確定其成分。不同濃度的黑殭菌素B 作用於HT-29 細胞株有其明顯的抑制效果，並呈現劑量相關趨勢。在48 小時作用後，黑殭菌素B 對於HT-29 細胞株的細胞半抑制濃度為(IC50 )為2μM。在動物實驗結果中顯示，低劑量的黑殭菌素B (0.6 mg/kg/day) 能夠抑制荷瘤老鼠 (xenograft) 腫瘤生長。無論是以黑殭菌素B 或是臨床大腸癌用藥5-FU治療兩周後，caspase-3 可被活化。因此，黑殭菌素B 可望成為治療人類大腸癌腫瘤的新一代藥物。

關鍵字

黑殭菌素B ； 大腸癌 ； 人類大腸癌細胞HT-29 ； 裸鼠異種移殖 ； 5-氟尿嘧啶

並列摘要

Colon carcinoma is one of the most common malignant diseases worldwide. Previous studies reported destruxins B, one of the secondary metabolites of Metarhiziu anisopliae has potent growth suppression effect on human HT-29 adenocarcinoma cells. The purpose of this study is to compare, in vitro and in vivo, the anti-colon cancer activities of destruxin B and investigate the in vivo anti-colon cancer pathway of destruxin B. The destruxins were isolated and purified according to the previous report (Chen et al., 1999) and characterized by HPLC, ESI-MASS and 1H NMR spectroscopies. A significant inhibition in cell viability was observed upon treatments with various concentrations of destruxin B and was in a dose-dependent manner. The IC50 of destruxin B at 48 hours was 2μM on HT-29. At the end of the experiment, Destruxin B, at low dose concentration ( 0.6 mg/kg/day) could inhibit tumor growth in a xenograft mice model and the caspase-3 is activated after 2 weeks treatment of destruxin B. In conclusion, destruxin B was suggested potentially to be explored as a new therapeutic agent against human colorectal carcinoma cancer.

並列關鍵字

Destruxin B ； HT-29 ； 5-FU ； Xenograft ； Colon Cancer

參考文獻

Liu Bing-Lan, Rou Tzyy-Min, Rao Yerra Koteswara, and Tzeng Yew-Min, 2007, Effect of pH and Aeration Rate on the Production of Destruxins A and B from Metarhizium anisopliae. International Journal of Applied Science and Engineering, 5(1):17-26.

Liaw YP, Chen CJ, Lee WC, and Hsu SY, 2003, The construction and use of the electric atlas of cancer mortality and incidence in Taiwan. Taiwan J Public Health (Taipei), 22(3):227-236.

Taiwan Cancer Registry Annual Report, 2002, Republic of China. Bureau of Health Promotion, Department of Health, Executive Yuan, Republic of China, 2002.

Heer Pieter de, Bruin Elza C. de, Elma Klein-Kranenbarg, Aalbers Remco I.J.M., Marijnen Corrie A.M., Putter Hein, Bont Hans J. de, Nagelkerke J. Fred, J. Han JM van Krieken, Hein W. Verspaget, CornelisJ.H. van deVelde,and Peter J.K. Kuppen, for the Dutch Colorectal Cancer Group, 2007, Caspase-3 activity predicts local recurrence in rectal cancer. Clin Cancer Res. ,13(19):5810-5815.

Peng Kou-Cheng, Huang Hsuan-Shun, Tzeng Yew-Min, and Liu Shu-Ying, 2005, Circular dichroism analysis of destruxins from Metarhizium anisopliae. Journal of Biochemical and Biophysical Methods, 62(1):41-50.